Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boehringer Ingelheim, Emalex, Harmony, Ironwood, J&J, Lineage Cell, Longeveron, Medivir, Merck & Co., Modus, Nanobiotix, Neucrocrine, Nuvalent, Okyo, Promontory, Regeneron, Roche, Tenaya and Zealand.